Authors


Rebecca Silver

Latest:

Successful Digital Transformation Depends on Quality Customer Data

Companies recognize that their success with digital starts with accurate customer data, but many struggle to manage the overwhelming volume of different data types from hundreds of sources.


Venu Mallarapu, Brand Insights Contributor, Senior Director of Life Sciences and Global Head for the Cognizant R&D Solutions Group

Latest:

Five Steps for Automating the Pharmacovigilance Process

Here’s how pharma businesses can speed the handling of adverse events, reduce costs, improve patient safety and spur growth through pharmacovigilance automation.


Francis Pollaro

Latest:

Q&A With Daniel Lofaso, CEO of Digital Elevator

Lofaso discusses strategies that biotech companies can take once its time to make the big push.


Estelle Ricoux

Latest:

The Future of Personalized Medicine Hinges on Pharma Executives Revolutionizing Business Models

The era of big pharma as product-first companies must end, as services become the larger priority.


Rebecca L. Rakoski, Esq.

Latest:

Examining Data Breaches in Pharma Companies During COVID-19

Pharma companies are struggling to maintain a high level of cybersecurity amidst the pandemic.


Spencer Gore

Latest:

How Leaders Can Empower Their People to be Their Best

If you wish for your team to be diligent, innovative, and collaborative, you must first exhibit these traits yourself


Haydn Boehm

Latest:

Embracing the Renaissance of Small Molecule Drug Discovery

Pharma companies may benefit from meeting challenges and embracing small molecule drug discovery.


David Medina Tato

Latest:

Four Key Strategies for Optimizing Your Medical Congress Strategy

Conferences, congresses, and the digital discussions kicked off by those events create a halo effect that amplifies scientific information more so than other scientific activities.


Erik Moen

Latest:

Operating Models for Successful DOL Engagement

How life sciences companies can design an effective operating model for DOL engagements.



Jane Z. Reed

Latest:

Accelerating Rare Disease Drug Development with NLP: Three Use Cases

Utilizing natural language processing technologies to improve search capabilities and advance the development of therapies.


Stacy Hartung

Latest:

Bridging the Divide: Medical's Omnichannel Momentum

How pharma medical affairs and commercial teams are synchronizing their capabilities to boost omnichannel marketing strategies and better understand customer engagement needs.


Mel Walker

Latest:

A Brave New World: Optimizing Access in Wake of COVID

The top changes necessary in planning and designing pharma market access plans, including a revamp of the payer-value equation at pivotal points in the product life cycle.


TruTag Technologies, Inc.

Latest:

The Future of Medicine is Smart

This white paper describes how digitizing medicines can drive patient engagement, reduce non-adherence, and enhance supply chain visibility.


Brenna E. Jenny

Latest:

In DOJ Crosshairs: Rethinking Commission-Based Deals With Independent Contractors

Pharma companies should review their commission-based compensation arrangements with independent contractors to address enforcement risk under the Anti-Kickback Statute, in light of recent Department of Justice enforcement.


Ed Shankman

Latest:

The Value Cornerstone: Bridging the Pharma Marketing Gap

Brand positioning that targets HCPs is often irrelevant to the payer mindset. Fortunately, market access teams have an option, writes Ed Shankman.


Bill Barr, Carl Hart, and Zack Blacker

Latest:

Foundational Questions in Data Reporting, Analytics to Meet Reimbursement-Directed Marketing Goals

Measuring the relationship between a product’s reimbursement position and performance begins with gathering key data points for as many products as possible.



Dan Schulman

Latest:

Staying the Course: Double Down on Launch Agility

In today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.


Arturo Loaiza-Bonilla

Latest:

Health Equity Barriers in Oncology Trials

Overcoming persistent barriers to health equity in oncology trials will require innovation and cooperation.






Srini Rajamani

Latest:

Leveraging Technology for Pharmaceutical Commercialization

With AI/ML and cognitive technologies set to become a key enabler of the pharma commercialization process, Srini Rajamani outlines how pharma companies can leverage tech effectively.



Linda Mayer

Latest:

How to Conduct More Impactful Patient and Caregiver Advisory Boards

Looking to hold an advisory board? Here are a few suggestions.


Michelle Sims

Latest:

Three Ways to Close the Urgent Talent Gap

The industry has struggled to recruit talent for years, and the challenge is only getting more difficult. Pharma companies need to recruit differently.


Datacubed Health

Latest:

Patient Experience Breakthroughs: Leveraging the Latest Digital Tools and Techniques to Optimize your Patient Experience Goals

Learn how breakthrough patient experience strategies can help achieve your study goals in this upcoming webcast. Lead by renowned neuroscientist and behavioral economist Dr. Paul Glimcher, it’s the one webcast this year your team can’t afford to miss. Live: Tuesday, May 19, 2020 at 1pm EDT | 12pm CDT | 10am PDT On demand available after airing until May 19, 2021.


Sonia Fiorenza

Latest:

Recruiting and Retaining Talent Is the Biggest Challenge Facing the Pharmaceutical Industry

Recent increases in employee burnout and turnover must be addressed.